Dicerna Pharmaceuticals to Present at Upcoming Conferences

Published: Feb 28, 2011

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Dicerna), a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technologyâ„¢ and Dicer Substrate siRNA (DsiRNA) molecules, today announced that the company will be presenting at the following conferences in March and April:

Back to news